Ropes & Gray LLP’s transactional tax team advises a wide range of clients, including public and private companies, private equity firms, tax-exempt organizations, and asset managers on the tax aspects of M&A, financings, restructurings, and spin-offs, among other issues. The team has a particularly strong reputation for its work in the biotech/ life sciences space, including in relation to licensing and collaboration agreements. Elaine Murphy, with considerable experience advising institutional and global investors, fund sponsors and advisers, and multinational companies on international and US tax matters, chairs the practice. James Brown in New York advises several leading private equity sponsors and investment advisors on a wide range of matters, including M&A, recapitalizations, joint ventures, and fund structuring. Pamela Glazier represents middle-market and premier private equity firms operating in the banking, tech, retail, and life sciences sectors, among others, as well as registered investment companies on transactional and mutual funds matters. Adam Greenwood in New York advises global asset managers and private equity sponsors, while David Saltzman concentrates on international tax matters, advising multinationals, financial institutions investment funds, and global investors. Amanda Holt focuses on transactional tax, including corporate and partnership taxation. Tristan Evans-Wilent, Samuel Duncan, Franziska Hertel, and Brandon Dunn were all promoted to partnership in November 2023. All lawyers mentioned are based in Boston, unless stated otherwise.
Key clients
- Bain Capital
- Pfizer
- Advent International
- Dragoneer Investment Group
- University of Southern California
- Immunogen
- HarbourVest Partners
- Altamont Capital
- TSG Consumer Partners
- GHO Capital Partners
- Audax Group
- Harvest Partners
- Constitution Capital Partners
- Welsh Carson Anderson & Stowe
- Vistria Group
- New Mountain Capital
- Genstar Capital
Work highlights
- Advised Pfizer on strategic investments, including several cross-border venture capital investments, restructurings and novel joint ventures and other arrangements to foster cutting edge research and development.
- Represented Signify Health in its $8 billion sale to CVS Health.
- Advised Constitution Capital Partners in the close of $1.1 billion across two midmarket investment strategies.
Practice head
The lawyer(s) leading their teams.
Elaine Murphy